• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CHEK2 mutations in primary glioblastomas.

作者信息

Sallinen Satu-Leena, Ikonen Tarja, Haapasalo Hannu, Schleutker Johanna

出版信息

J Neurooncol. 2005 Aug;74(1):93-5. doi: 10.1007/s11060-005-5953-7.

DOI:10.1007/s11060-005-5953-7
PMID:16078115
Abstract
摘要

相似文献

1
CHEK2 mutations in primary glioblastomas.原发性胶质母细胞瘤中的CHEK2突变
J Neurooncol. 2005 Aug;74(1):93-5. doi: 10.1007/s11060-005-5953-7.
2
Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas.胶质母细胞瘤中hBUB1、hBUBR1和hBUB3基因的突变分析
Acta Neuropathol. 2001 Apr;101(4):297-304. doi: 10.1007/s004010100366.
3
Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme.CHEK2基因变异作为多形性胶质母细胞瘤的预后标志物
Neurosurgery. 2006 Nov;59(5):1078-85; discussion 1085. doi: 10.1227/01.NEU.0000245590.08463.5B.
4
Mutations of the PIK3CA gene are rare in human glioblastoma.PIK3CA基因的突变在人类胶质母细胞瘤中很罕见。
Acta Neuropathol. 2005 Jun;109(6):654-5. doi: 10.1007/s00401-005-1001-0. Epub 2005 May 28.
5
Mutational analysis of the CITED4 gene in glioblastomas.胶质母细胞瘤中CITED4基因的突变分析。
Cancer Genet Cytogenet. 2008 Sep;185(2):114-6. doi: 10.1016/j.cancergencyto.2008.05.013.
6
PIK3CA mutations in glioblastoma multiforme.多形性胶质母细胞瘤中的PIK3CA突变
Acta Neuropathol. 2005 Jun;109(6):639-42. doi: 10.1007/s00401-005-1000-1. Epub 2005 May 28.
7
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.端粒酶逆转录酶（TERT）启动子突变与rs2853669多态性：对胶质母细胞瘤的预后影响及与常见改变的相互作用
J Neurooncol. 2016 Feb;126(3):441-6. doi: 10.1007/s11060-015-1999-3. Epub 2015 Nov 25.
8
p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.胶质母细胞瘤中的p53突变与表皮生长因子受体过表达
J Korean Med Sci. 2001 Aug;16(4):481-8. doi: 10.3346/jkms.2001.16.4.481.
9
Adult classical glioblastoma with a BRAF V600E mutation.伴有BRAF V600E突变的成人经典型胶质母细胞瘤。
World J Surg Oncol. 2015 Mar 11;13:100. doi: 10.1186/s12957-015-0521-x.
10
[PCR-SSCP analysis of p53 gene in human primary brain tumor].[人脑原发性肿瘤中p53基因的聚合酶链反应-单链构象多态性分析]
Hua Xi Yi Ke Da Xue Xue Bao. 1997 Mar;28(1):45-9.

引用本文的文献

1
Explainable Machine Learning Models for Glioma Subtype Classification and Survival Prediction.用于脑胶质瘤亚型分类和生存预测的可解释机器学习模型
Cancers (Basel). 2025 Aug 9;17(16):2614. doi: 10.3390/cancers17162614.
2
Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies.多形性胶质母细胞瘤：对发病机制、关键信号通路及治疗策略的见解
Mol Cancer. 2025 Feb 26;24(1):58. doi: 10.1186/s12943-025-02267-0.
3
Prevalence of pathogenic germline variants in adult-type diffuse glioma.成人型弥漫性胶质瘤中致病性种系变异的患病率。

本文引用的文献

1
CHEK2 variant I157T may be associated with increased breast cancer risk.CHEK2基因变异体I157T可能与乳腺癌风险增加有关。
Int J Cancer. 2004 Sep 10;111(4):543-7. doi: 10.1002/ijc.20299.
2
CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.CHEK2基因1100位密码子C缺失与乳腺癌易感性：一项涉及来自10项研究的10860例乳腺癌病例和9065例对照的协作分析。
Am J Hum Genet. 2004 Jun;74(6):1175-82. doi: 10.1086/421251. Epub 2004 Apr 30.
3
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.
Neurooncol Pract. 2023 Jun 21;10(5):482-490. doi: 10.1093/nop/npad033. eCollection 2023 Oct.
4
mutations in pediatric brain tumors.小儿脑肿瘤中的突变
Neurooncol Adv. 2023 Apr 14;5(1):vdad038. doi: 10.1093/noajnl/vdad038. eCollection 2023 Jan-Dec.
5
Alterations in Pediatric Malignancy: A Single-Institution Experience.小儿恶性肿瘤的变化：单机构经验
Cancers (Basel). 2023 Mar 8;15(6):1649. doi: 10.3390/cancers15061649.
6
The First Case Report of a Patient With Oligodendroglioma Harboring Germline Mutation.首例携带胚系突变的少突胶质细胞瘤患者的病例报告
Front Genet. 2022 Feb 23;13:718689. doi: 10.3389/fgene.2022.718689. eCollection 2022.
7
Is a moderate-risk breast cancer gene or the younger sister of Li-Fraumeni?是一种中度风险乳腺癌基因，还是李-佛美尼症候群的妹妹？
BMJ Case Rep. 2020 Sep 7;13(9):e236435. doi: 10.1136/bcr-2020-236435.
8
tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia.伴有间变的毛细胞型星形细胞瘤中的酪氨酸激酶结构域重复
Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). doi: 10.1101/mcs.a002378. Print 2018 Apr.
9
Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors.脑肿瘤中相关关键基因与信号多样性的探索。
Cell Mol Neurobiol. 2018 Mar;38(2):393-419. doi: 10.1007/s10571-017-0498-9. Epub 2017 May 10.
10
CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.CHEK2（∗）1100delC突变与前列腺癌风险
Prostate Cancer. 2014;2014:294575. doi: 10.1155/2014/294575. Epub 2014 Nov 6.
CHEK2*1100delC变异体在非BRCA1/BRCA2多病例家族中作为乳腺癌风险修饰因子发挥作用。
Cancer Res. 2003 Dec 1;63(23):8153-7.
4
CHEK2 variants associate with hereditary prostate cancer.CHEK2基因变异与遗传性前列腺癌相关。
Br J Cancer. 2003 Nov 17;89(10):1966-70. doi: 10.1038/sj.bjc.6601425.
5
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.CHEK2基因1100delC突变可识别出具有遗传性乳腺癌和结直肠癌表型的家族。
Am J Hum Genet. 2003 May;72(5):1308-14. doi: 10.1086/375121. Epub 2003 Apr 10.
6
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.除1100delC之外，CHEK2基因的其他变异对乳腺癌易感性的影响不大。
Am J Hum Genet. 2003 Apr;72(4):1023-8. doi: 10.1086/373965. Epub 2003 Feb 27.
7
Mutations in CHEK2 associated with prostate cancer risk.与前列腺癌风险相关的CHEK2基因突变。
Am J Hum Genet. 2003 Feb;72(2):270-80. doi: 10.1086/346094. Epub 2003 Jan 17.
8
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.一种CHEK2基因变异导致相当一部分家族性乳腺癌。
Am J Hum Genet. 2002 Aug;71(2):432-8. doi: 10.1086/341943. Epub 2002 Jul 28.
9
Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2.肿瘤抑制激酶Chk2在DNA损伤信号传导中FHA结构域的结构与功能多样性
Mol Cell. 2002 May;9(5):1045-54. doi: 10.1016/s1097-2765(02)00527-0.
10
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.在 BRCA1 或 BRCA2 基因无突变的个体中，CHEK2(*)1100delC 导致的乳腺癌低外显率易感性。
Nat Genet. 2002 May;31(1):55-9. doi: 10.1038/ng879. Epub 2002 Apr 22.